ABSTRACT
A large-scale study was carried out in the Polish goat population in 2014-2021 to determine the herd-level true seroprevalence (HTP) of caseous lymphadenitis (CLA) caused by Corynebacterium pseudotuberculosis (Cp) and paratuberculosis (PTB) caused by Mycobacterium avium ssp. paratuberculosis (Map). Two-stage cluster sampling was applied to herds counting at least 20 adult goats (aged >1 year) and in each herd all males and 10-13 females were tested. At least one seropositive goat regardless of its sex was necessary to consider the herd as infected. HTP was estimated using the Bayesian approach with the Gibbs sampler in the EpiTools and reported as the median and 95â¯% credibility interval (95â¯% CrI). A total of 1282 adult goats from 86 herds were serologically tested using two commercial ELISAs (Cp-ELISA and Map-ELISA). At least 1 seropositive result of Cp-ELISA and Map-ELISA was obtained in 73/86 herds (84.9â¯%) and 40/86 herds (46.5â¯%), respectively. HTP of CLA was estimated at 73.3â¯% (95â¯% CrI: 65.0â¯%, 80.4â¯%) and HTP of PTB was estimated at 42.9â¯% (95â¯% CrI: 25.8â¯%, 58.0â¯%). There was a significant positive association between the occurrence of CLA and PTB in the herds (odds ratio 6.0, 95â¯% confidence interval: 1.2, 28.8; p = 0.010). Probability of the seropositive result for PTB was also significantly higher in Cp-seropositive goats than in Cp-seronegative goats (odds ratio 3.9, 95â¯% confidence interval: 2.4, 6.3; p < 0.001) which could indicate either a higher risk of co-infection or a higher rate of false positive results for PTB in Cp-positive goats. To investigate this issue, optical densities obtained in Map-ELISA were compared between Cp-positive and Cp-negative goats and results of Map-ELISA were adjusted accordingly. Map-negative sera from Cp-positive goats turned out to have significantly higher optical densities than Map-negative sera from Cp-negative goats (p < 0.001). After the adjustment, the herd-level apparent seroprevalence of PTB was 41.9â¯% (36/86 herds) so it still fell within the 95â¯% CrI of HTP of PTB calculated before the adjustment. Concluding, CLA appears to be widespread in the Polish goat population. In many of them it may be subclinical at the moment, however will likely emerge in the future as the disease follows cyclic pattern in Poland. On the other hand, given the total lack of clinical PTB in Polish goats, an explanation for a high HTP of PTB remains unclear and warrants further studies using tests of higher analytical specificity than ELISA.
Subject(s)
Corynebacterium pseudotuberculosis , Enzyme-Linked Immunosorbent Assay , Goat Diseases , Goats , Mycobacterium avium subsp. paratuberculosis , Paratuberculosis , Animals , Paratuberculosis/epidemiology , Paratuberculosis/blood , Paratuberculosis/microbiology , Seroepidemiologic Studies , Goat Diseases/epidemiology , Goat Diseases/microbiology , Goat Diseases/blood , Poland/epidemiology , Mycobacterium avium subsp. paratuberculosis/isolation & purification , Corynebacterium pseudotuberculosis/isolation & purification , Female , Male , Enzyme-Linked Immunosorbent Assay/veterinary , Corynebacterium Infections/veterinary , Corynebacterium Infections/epidemiology , Corynebacterium Infections/microbiology , Lymphadenitis/veterinary , Lymphadenitis/epidemiology , Lymphadenitis/microbiology , Bayes Theorem , PrevalenceABSTRACT
Finding an effective and well-tolerated treatment for canine idiopathic sebaceous adenitis (ISA) can be challenging. This case report describes an 8-year-old male Rottweiler with ISA successfully treated with a combination of oclacitinib and low doses of prednisolone.
Encontrar um tratamento eficaz e bem tolerado para a adenite sebácea idiopática (ISA) pode ser desafiador. Este relato descreve o caso de um cão Rottweiler macho de oito anos de idade tratado satisfatoriamente com uma associação de oclacitinib e baixas doses de prednisolona.
Encontrar un tratamiento efectivo y bien tolerado frente a la adenitis sebácea idiopática (ISA) puede ser un reto difícil. Este artículo describe el caso de un perro Rottweiler de ocho años tratado con eficacia con una combinación de oclacitinib y dosis bajas de prednisolona.
Trouver un traitement efficace et bien toléré pour l'adénite sébacée idiopathique canine (ASI) peut s'avérer difficile. Ce rapport clinique décrit le cas d'un Rottweiler mâle de 8 ans atteint d'ASI et traité avec succès par une combinaison d'oclacitinib et de faibles doses de prednisolone.
Subject(s)
Dermatitis , Dog Diseases , Lymphadenitis , Male , Dogs , Animals , Prednisolone/therapeutic use , Pyrimidines/therapeutic use , Sulfonamides/therapeutic use , Dermatitis/drug therapy , Dermatitis/veterinary , Dog Diseases/drug therapy , Lymphadenitis/drug therapy , Lymphadenitis/veterinaryABSTRACT
Citrobacter freundii, an opportunistic bacterial pathogen belonging to the family Enterobacteriaceae, has been sporadically reported in sea turtles. Here, the authors describe 3 unusual lesions associated with C. freundii infection in 3 loggerhead sea turtles stranded on the coast of Gran Canaria Island, Spain. It is possible that these 3 distinct lesions played a major role in the death of these turtles. The first turtle had caseous cholecystitis, a lesion not previously described in sea turtles. The second turtle had large intestinal diverticulitis, a rare condition in loggerheads. The third turtle had bilateral caseous salt gland adenitis. Histologically, numerous gram-negative bacilli were observed at the deepest edge of inflammation in all cases. Pure cultures of C. freundii were obtained from these 3 lesions. Molecular detection of C. freundii DNA in formalin-fixed paraffin-embedded samples from the lesions of the 3 turtles confirmed the microbiological isolation. These cases, in addition to expanding the limited body of knowledge on bacterial infections in sea turtles, highlight the potential pathogenic role of C. freundii in loggerhead turtles.
Subject(s)
Lymphadenitis , Turtles , Animals , Citrobacter freundii , Turtles/microbiology , Inflammation/veterinary , Lymphadenitis/veterinary , SpainABSTRACT
Background: Caseous lymphadenitis (CLA) is a chronic suppurative bacterial infection caused by Corynebacterium pseudotuberculosis (C. pseudotuberculosis) affecting superficial and internal lymph nodes and internal organs of small ruminants. Aims: Through the use of molecular methods, this study aimed to estimate the prevalence of CLA and its contributing factors as well as the degree of genetic diversity and epidemiological relationships among C. pseudotuberculosis isolates from slaughtered sheep and goats in various districts of Duhok Province, Iraq. Methods: A total of 18,836 carcasses (15,775 sheep and 3,061 goats) were inspected by veterinarians at slaughterhouses [Duhok-Sumel (2,453 sheep + 627 goats), Zakho (6,000 sheep), Bardarash (1,117 sheep + 379 goats), Amedi (413 sheep + 178 goats) and Akre (5,792 sheep + 1,877 goats)] in Duhok Province for detection the prevalence rate of CLA using molecular techniques. Results: The prevalence of the disease was 0.94% and 1.93% in sheep and goats, respectively. Sheep in Duhok-Sumel and goats in Amedi were at a higher risk of infection than the animals in another location, with a prevalence rate of 4.31% and 6.18%, respectively. Sheep and goats of older age were more susceptible. Females were more susceptible than males in all districts except Duhok-Sumel where the reverse was true. ERIC-PCR analysis grouped the bacterial isolates into 11 different genotypes. The maximum likelihood phylogenetic tree of partial sequences of the 16S rRNA gene sequences of C. pseudotuberculosis revealed no divergent sequences discovered in this study. Conclusion: A strict control program needs to be applied to reduce the entrance of pathogen from neighboring countries.
Subject(s)
Goat Diseases , Lymphadenitis , Sheep Diseases , Female , Male , Sheep , Animals , Goats , Molecular Epidemiology , Iraq/epidemiology , Phylogeny , RNA, Ribosomal, 16S , Lymphadenitis/epidemiology , Lymphadenitis/veterinary , Goat Diseases/epidemiology , Sheep Diseases/epidemiologyABSTRACT
Caseous lymphadenitis (CLA), an infectious disease caused by Corynebacterium pseudotuberculosis in small ruminants, is highly prevalent worldwide. Economic losses have already been associated with the disease, and little is known about the host-pathogen relationship associated with the disease. The present study aimed to perform a metabolomic study of the C. pseudotuberculosis infection in goats. Serum samples were collected from a herd of 173 goats. The animals were classified as controls (not infected), asymptomatic (seropositives but without detectable CLA clinical signs), and symptomatic (seropositive animals presenting CLA lesions), according to microbiological isolation and immunodiagnosis. The serum samples were analyzed using nuclear magnetic resonance (1H-NMR), nuclear Overhauser effect spectroscopy (NOESY), and Carr-Purcell-Meiboom-Gill (CPMG) sequences. The NMR data were analyzed using chemometrics, and principal component analysis (PCA) and partial least square discriminant analysis (PLS-DA) were performed to discover specific biomarkers responsible for discrimination between the groups. A high dissemination of the infection by C. pseudotuberculosis was observed, being 74.57% asymptomatic and 11.56% symptomatic. In the evaluation of 62 serum samples by NMR, the techniques were satisfactory in the discrimination of the groups, being also complementary and mutually confirming, demonstrating possible biomarkers for the infection by the bacterium. Twenty metabolites of interest were identified by NOESY and 29 by CPMG, such as tryptophan, polyunsaturated fatty acids, formic acid, NAD+, and 3-hydroxybutyrate, opening promising possibilities for the use of these results in new therapeutic, immunodiagnosis, and immunoprophylactic tools, as well as for studies of the immune response against C. pseudotuberculosis. KEY POINTS: ⢠Sixty-two samples from healthy, CLA asymptomatic, and symptomatic goats were screened ⢠Twenty metabolites of interest were identified by NOESY and 29 by CPMG ⢠1H-NMR NOESY and CPMG were complementary and mutually confirming.
Subject(s)
Corynebacterium Infections , Corynebacterium pseudotuberculosis , Lymphadenitis , Animals , Corynebacterium pseudotuberculosis/metabolism , Goats/microbiology , Lymphadenitis/diagnosis , Lymphadenitis/veterinary , Lymphadenitis/microbiology , Corynebacterium Infections/diagnosis , Corynebacterium Infections/veterinary , Corynebacterium Infections/microbiology , Magnetic Resonance SpectroscopyABSTRACT
Between 2009 and 2018, five common bottlenose dolphins (Tursiops truncatus) at the US Navy Marine Mammal Program presented with superficial cervical lymphadenitis. Clinical findings included ultrasonographic evidence of cervical lymph node enlargement, severe leukocytosis, elevated erythrocyte sedimentation rates, and reduced serum iron. Three of the dolphins presented with clinicopathologic changes without presence of clinical signs, and the other two cases additionally presented with partial to complete anorexia, lethargy, and refusal to participate in training sessions. Ultrasound-guided fine needle aspiration or biopsy of the affected lymph nodes yielded Streptococcus phocae by PCR in all cases, and the organism was cultured in one of five cases. Animals were treated with a combination of enteral, parenteral, intralesional antimicrobial, or a combination of those therapies and supportive care. Time to resolution of clinical disease ranged between 62 and 188 days. To the authors' knowledge, this is the first report of Streptococcus phocae cervical lymphadenitis in cetaceans. Streptococcus phocae lymphadenitis should be a differential for cervical lymphadenopathy in this species, especially when associated with pronounced systemic inflammation and a history of potential exposure.
Subject(s)
Bottle-Nosed Dolphin , Lymphadenitis , Animals , Inflammation/pathology , Inflammation/veterinary , Lymph Nodes/pathology , Lymphadenitis/veterinaryABSTRACT
Caseous lymphadenitis (CLA), an infectious disease caused by Corynebacterium pseudotuberculosis in goats and sheep, is highly prevalent worldwide and is characterized by economic losses in small ruminant production. Currently available techniques for clinical and laboratory diagnosis of the disease lack market availability and/or sensitivity, and therefore, infected animals can remain in the herd, serving as a source of infection for other animals. The present study aimed to verify hematological and clinical biochemistry changes in goats naturally infected by C. pseudotuberculosis. One hundred seventy-three Canindé goats were included in this study, from which blood samples and caseous lesions were collected. The animals were classified as uninfected, asymptomatic, and symptomatic according to microbiological isolation and serological assays. A high dissemination of the infection was observed in the herd, with 86.13% of positive animals, being 74.57% asymptomatic and 11.56% symptomatic. In the hemogram and clinical biochemistry analyses, the only statistical difference found was a higher level of serum urea in asymptomatic individuals than in non-infected animals. In addition, this study points to the possibility of chronic CLA being potentially reflected in hepatic and renal biochemical markers.
Subject(s)
Corynebacterium Infections , Corynebacterium pseudotuberculosis , Goat Diseases , Lymphadenitis , Sheep Diseases , Sheep , Animals , Goat Diseases/microbiology , Sheep Diseases/microbiology , Lymphadenitis/veterinary , Goats , Corynebacterium Infections/veterinaryABSTRACT
Corynebacterium pseudotuberculosis is a bacillus that causes caseous lymphadenitis in small ruminants, leading to great losses to rural producers; thus, an efficient diagnosis is necessary for using disease control measures. This study aimed to evaluate the antigenic potential of four C. pseudotuberculosis recombinant proteins (rSodC, rPknG, rNanH, and rSpaC) against sera of goat and sheep experimentally infected with one of three different C. pseudotuberculosis strains. Goats were infected with CAP76 or CAP21 strain (n = 10), sheep with VD57 strain (n = 6), and a group of not-infected animals (goats and sheep) were kept as a healthy control (healthy n = 12). Sera were collected at 0, 14, 60, 90, 180, or 190 days after inoculation for antigenicity testing using Western blotting and enzyme-linked immunosorbent assay (ELISA) techniques. Cross-reactivity tests with recombinant proteins were performed in goat serum experimentally vaccinated with Nocardia sp. or Rhodococcus equi bacterin. The rSodC protein showed discriminatory antigenic reactivity with a statistically significant difference against three different C. pseudotuberculosis strains evaluated in goats and sheep samples, while rPknG showed statistical significance only against two C. pseudotuberculosis strains evaluated in goats. rSodC was proved to be a strong candidate as a tool for diagnosis of C. pseudotuberculosis infection, once it was able to recognize antibodies against all strains evaluated in goats and sheep.
Subject(s)
Corynebacterium Infections , Goat Diseases , Lymphadenitis , Sheep Diseases , Animals , Corynebacterium Infections/diagnosis , Corynebacterium Infections/microbiology , Corynebacterium Infections/veterinary , Goat Diseases/diagnosis , Goat Diseases/microbiology , Goat Diseases/prevention & control , Goats , Lymphadenitis/diagnosis , Lymphadenitis/microbiology , Lymphadenitis/veterinary , Recombinant Proteins/genetics , Sheep , Sheep Diseases/diagnosis , Sheep Diseases/microbiologyABSTRACT
Although equine strangles is reportable in all states, synchronous reporting of this disease does not occur across the country. States have variable regulations on reporting (actionable, notifiable, and monitored) and no mandatory comprehensive databases exist for tracking prevalence. In this study, we solicited veterinarians' opinions on reporting of strangles and factors influencing their opinion. Two hundred and fifty veterinarians practicing within the United States A structured survey was administered online. A total of 250 veterinarians participated: 84 participants (34%) believed that strangles should continue to be nationally monitored and that individual states should have jurisdiction over laboratory-confirmed positive cases; 58 (23.2%) believed strangles should become nationally monitored with mandatory notification of positive cases to a central forum; 24 participants (9.6%) thought strangles should become notifiable nationally; and 44 (17.6%) thought strangles should become notifiable and actionable. Veterinarians who were currently in the habit of reporting strangles were also more likely to want increased reporting (Or=1.87), though this association was not quite statistically significant (P = 0.054), as did veterinarians who ranked strangles as "very important" or "important" relative to other infectious disease (OR 3.77, P = .037). Veterinarians practicing in the Southwest (P = .01) and West (P = .04) were significantly less likely than northeast practitioners to rank strangles of higher importance. Opinions on equine strangles and desire for increased reporting were varied in the sampled veterinary community. Information obtained in this study regarding veterinarians' current views on strangles reporting could inform future policy regarding the disease.
Subject(s)
Communicable Diseases , Horse Diseases , Lymphadenitis , Streptococcal Infections , Veterinarians , Animals , Communicable Diseases/veterinary , Horse Diseases/epidemiology , Horses , Humans , Lymphadenitis/veterinary , Streptococcal Infections/epidemiology , Streptococcal Infections/veterinary , Surveys and Questionnaires , United States/epidemiologyABSTRACT
A 2.5-year-old castrated male cat presented with fever and marked generalized lymphadenopathy of 4-months duration, despite treatment with amoxicillin-clavulanate/marbofloxacin. Abnormalities were not detected on complete blood count, serum chemistry, and FIV/FeLV test apart from a borderline, non-regenerative anemia. Peripheral lymph node fine needle aspirations revealed a marked increase in the percentage of intermediate- and lymphoblastic-lymphocytes in addition to reactive macrophages. Three weeks after presentation, the cat developed a severe, regenerative, immune-mediated hemolytic anemia (IMHA) which responded to immunosuppressive therapy. Fever and lymphadenopathy persisted. Peripheral lymph nodes tested positive for Bartonella henselae DNA in real-time PCR assay and sequencing. Treatment with pradofloxacin and doxycycline resulted in resolution of clinical signs, and negative PCR tests. Despite its reported low pathogenicity, B. henselae infection should also be considered in cats with protracted unexplained fever, lymphadenitis, and IMHA. Furthermore, a combination of pradofloxacin and doxycycline might be considered in cats with bartonellosis given its apparent clinical efficacy.
Subject(s)
Anemia, Hemolytic, Autoimmune , Bartonella Infections , Bartonella henselae , Cat Diseases , Cat-Scratch Disease , Lymphadenitis , Lymphadenopathy , Anemia, Hemolytic, Autoimmune/drug therapy , Anemia, Hemolytic, Autoimmune/veterinary , Animals , Bartonella Infections/drug therapy , Bartonella Infections/veterinary , Cat Diseases/diagnosis , Cat Diseases/drug therapy , Cat-Scratch Disease/complications , Cat-Scratch Disease/diagnosis , Cat-Scratch Disease/drug therapy , Cat-Scratch Disease/veterinary , Cats , Doxycycline/therapeutic use , Fever/veterinary , Lymphadenitis/drug therapy , Lymphadenitis/veterinary , Lymphadenopathy/complications , Lymphadenopathy/drug therapy , Lymphadenopathy/veterinary , MaleSubject(s)
Dog Diseases , Lymphadenitis , Lymphadenopathy , Peritonitis , Abscess/pathology , Abscess/veterinary , Animals , Dog Diseases/diagnosis , Dog Diseases/pathology , Dogs , Lymph Nodes/pathology , Lymphadenitis/diagnosis , Lymphadenitis/pathology , Lymphadenitis/veterinary , Lymphadenopathy/pathology , Lymphadenopathy/veterinary , Peritonitis/diagnosis , Peritonitis/pathology , Peritonitis/veterinaryABSTRACT
BACKGROUND: Caseous lymphadenitis (CLA) is a chronic bacterial infectious disease that affects cattle, shoats, and other domestic and wild ruminants. METHODS: A purposive cross-sectional study was conducted on 30 cattle with enlarged lymph nodes to investigate CLA using cytopathological and bacteriological techniques from cattle slaughtered at Bishoftu municipal abattoir. RESULTS: From a total of 30 cattle subjected to clinical and post-mortem examinations, only one bull was found to be infected with a rare case of CLA in Bishoftu municipal abattoir, Ethiopia. Enlargement of the pre-scapular lymph node was the only clinical finding during ante-mortem inspection of the bull. The gross pathological lesion showed a pre-scapular lymph node with a caseo-necrotic dystrophic calcification that was accompanied by a rough texture and white to grayish hue. Histopathologically, the lymph node was characterized by central liquefactive necrosis that was surrounded by coagulative necrosis containing multiple foci of mineralization, infiltration of polymorphonuclear neutrophils and mononuclear immature fibrosis containing inflammatory cells and also with some sort of a thick layer of mature fibrosis that defines the magnitude of the lesion. Cytologically, multi-lobulated (intact and degenerated) neutrophils, a few reactive lymphocytes, macrophages and some crenated histocytes have been recognized. The bacterial culture of the sample revealed small, white cream, dry, waxy colonies with a narrow area of ß-haemolysis. The isolate of the sample was a Gram-positive cocci-bacilli that was arranged in a Chinese pattern on Gram staining, and catalase and urease were positive in the biochemical analysis of this organism, which was able to ferment glucose and maltose but not trehalose and xylose. CONCLUSIONS: The present investigation indicated that CLA was prevalent as sporadic cases among cattle slaughtered in Bishoftu municipal abattoir. Thus, effective preventive and control measures, such as good sanitation and hygiene, should be followed during meat inspection.
Subject(s)
Corynebacterium Infections , Lymphadenitis , Abattoirs , Animals , Bacteria , Cattle , Corynebacterium Infections/veterinary , Cross-Sectional Studies , Ethiopia/epidemiology , Fibrosis , Lymphadenitis/epidemiology , Lymphadenitis/microbiology , Lymphadenitis/veterinary , Male , Necrosis/veterinaryABSTRACT
Caseous lymphadenitis (CLA) is a chronic and insidious disease that mainly affects small ruminants and caused by Corynebacterium pseudotuberculosis (C. pseudotuberculosis). The aims of this research were to identify C. pseudotuberculosis by PCR from pyogenic lesions, to study the phylogenetic analysis of C. pseudotuberculosis and to detect the prevalence based on the detected superficial lesions of CLA in Dakahlia governorate, Egypt. Out of 3471 clinically examined animals, 129 (3.71%) animals were affected with CLA. The isolation rate of C. pseudotuberculosis in abscess of sheep was 45.74% (59/129). Out of 129 samples examined by PCR assay, 63 (48.83%) were positive phospholipase D (PLD) indicated at fragment size 203 bp. This is the first phylogenetic analysis study of C. pseudotuberculosis isolate in Egypt which was isolated from infected sheep. Nucleotide sequence identity data demonstrated that C. pseudotuberculosis PLD gene (MW187942) Dakahlia share homology 99.01%, 98.83 and 98.48% with Zagazig, Egypt (MN867024), Tamil nadu, India (MG720636) and Sudan (MG692441), respectively. In conclusion, this study provided information on the molecular detection and phylogeny of C. pseudotuberculosis in Egypt. Findings of this study can be conducted in other CLA endemic countries with similar animal breeding practices in the Middle East and developing countries.
Subject(s)
Corynebacterium Infections , Lymphadenitis , Sheep Diseases , Sheep , Animals , Egypt/epidemiology , India , Phylogeny , Sheep Diseases/epidemiology , Lymphadenitis/epidemiology , Lymphadenitis/veterinary , Lymphadenitis/diagnosis , Corynebacterium Infections/epidemiology , Corynebacterium Infections/veterinary , Corynebacterium Infections/microbiologyABSTRACT
Mycobacterial infections are rare in horses, donkeys and mules. Although there are a few reports in horses, mycobacterial disease is poorly documented in the donkey. Mycobacterial infection of equine species typically affects the alimentary tract, causing granulomatous enterocolitis resulting in diarrhoea and chronic weight loss, while lymph nodes and liver may also be affected. We now document recurrent oesophageal obstruction, secondary to cranial mediastinal lymphadenitis caused by Mycobacterium avium complex (MAC). To the best of our knowledge, this is the first report of MAC infection in a donkey in the UK.
Subject(s)
Esophageal Stenosis/veterinary , Horse Diseases , Lymphadenitis , Mycobacterium avium-intracellulare Infection , Animals , Equidae , Esophageal Stenosis/microbiology , Horses , Lymph Nodes , Lymphadenitis/veterinary , Mycobacterium avium Complex , Mycobacterium avium-intracellulare Infection/veterinaryABSTRACT
Caseous lymphadenitis (CLA) or pseudotuberculosis is a chronic zoonotic bacterial disease caused by Corynebacterium pseudotuberculosis, which affects livestock and humans. This study aimed to describe the pathology, bacteriology and confirm the identity of the pathogen by 16S rRNA gene sequencing in Camelus dromedarius. A total of 12 camels with suspected CLA in three regions of Abu Dhabi Emirate (Abu Dhabi, Al Ain and Al Dhafra), United Arab Emirate (UAE) were subjected to clinical and postmortem examinations from January 2015 to December 2020. Clinically, camels were emaciated and showed the presence of external caseous abscesses suggestive of CLA. Postmortem examination showed multiple abscesses of variable sizes with caseous material encapsulated by fibrous tissue in the liver, lungs, muscle, and lymph nodes. Following clinical and postmortem examination, blood, pus and different tissue samples were collected for subsequent analysis. Histopathological examination of all organs stained with Hematoxylin and Eosin (H&E) indicated a central caseo-necrotic core that was admixed with bacterial colonies and infiltration of chronic inflammatory cells, surrounded by a pyogenic membrane, and an outer fibrous connective tissue capsule. Bacterial culture identified the isolates of Corynebacterium pseudotuberculosis biotype ovis strain, and these isolates were shown to be sensitive to all antibiotics tested (penicillin, ampicillin, Co-trimoxazole, enrofloxacin and tetracycline). Moreover, the identity of the isolates was confirmed by partial sequencing of the 16S rRNA gene which showed a 100% identity to Corynebacterium pseudotuberculosis. Phylogenetic analysis based on 16S rRNA gene sequence clearly differentiates Corynebacterium pseudotuberculosis from other species of Corynebacterium. Briefly, this study provided the basic information for infection of Corynebacterium pseudotuberculosis in Camels and will help in controlling of this pathogen in the region.
Subject(s)
Animal Diseases/epidemiology , Corynebacterium Infections/complications , Corynebacterium/isolation & purification , Lymphadenitis/veterinary , Animal Diseases/microbiology , Animal Diseases/pathology , Animals , Anti-Bacterial Agents/administration & dosage , Camelus , Corynebacterium Infections/drug therapy , Corynebacterium Infections/microbiology , Female , Lymphadenitis/epidemiology , Lymphadenitis/microbiology , Lymphadenitis/pathology , Male , Time Factors , United Arab Emirates/epidemiologyABSTRACT
O objetivo deste trabalho foi avaliar a eficácia do florfenicol na dose usualmente empregada em equinos de 22 mg/kg pelas vias intravenosa, intramuscular e oral para o tratamento de adenite equina por Streptococcus equi. subsp. equi, usando a modelagem farmacocinética/farmacodinâmica (PK/PD Pharmacokinetic/Pharmacodynamic) e a simulação de Monte Carlo. Foi realizada uma simulação de Monte Carlo a partir dos parâmetros PK, logo depois, efetuou-se a modelagem PK/PD para determinar as taxas de eficácia do antimicrobiano para o tratamento dessa infecção bacteriana, de acordo com o valor da concentração inibitória mínima (CIM), em um intervalo de CIM de 0,125 4 μg/mL. Pela via intravenosa, a probabilidade de erradicação bacteriana foi de 100% para CIM até 0,5 μg/mL e efeito bacteriostático com probabilidades de 99% e 80% para CIMs de 2 e 4 μg/mL, respectivamente. Já pelas vias intramuscular e oral a probabilidade de se atingir o índice de erradicação bacteriológica foi de 100% para CIM de até 0,5 μg/mL, contudo, atinge valores de 80% e 81%, respectivamente, para CIM de 1 μg/mL considerando o efeito bactericida (p<0,01). Portanto, através desse estudo é evidenciado a eficácia do florfenicol até a CIM de 0,5 μg/mL para as três vias de administração citadas, entretanto, para CIMs superiores a esse valor, é imprescindível o ajuste da dose farmacológica, evitando falhas na terapêutica e possível resistência microbiana.
The objective of this study was to evaluate the efficacy of florfenicol at the dose usually used in horses of 22 mg/kg by intravenous, intramuscular and oral routes for the treatment of equine adenitis caused by Streptococcus equi. subsp. equi, using Pharmacokinetic/Pharmacodynamic (PK/PD) modeling and Monte Carlo simulation. A Monte Carlo simulation was performed from the PK parameters, then PK/PD modeling was performed to determine the antimicrobial efficacy rates for the treatment of this bacterial infection, according to the minimum inhibitory concentration (MIC) value, in a MIC range of 0.125 - 4 μg/mL. Intravenously, the probability of bacterial eradication was 100% for MICs up to 0.5 μg/mL, and the bacteriostatic effect was 99% and 80% for MICs of 2 and 4 μg/mL, respectively. However, for the intramuscular and oral routes, the probability of reaching the bacteriologic eradication index was 100% for MICs of up to 0.5 μg/mL, however, it reaches values of 80% and 81%, respectively, for MICs of 1 μg/mL considering the bactericidal effect (p<0.01). Therefore, through this study the efficacy of florfenicol is evidenced up to the MIC of 0.5 μg/mL for the three routes of administration cited, however, for MICs higher than this value, it is essential to adjust the pharmacological dose, avoiding failures in therapy and possible microbial resistance.
Subject(s)
Animals , Horses/physiology , Horses/injuries , Pharmacokinetics , Lymphadenitis/therapy , Lymphadenitis/veterinary , Thiamphenicol/analogs & derivatives , Thiamphenicol/pharmacokinetics , Thiamphenicol/pharmacology , Streptococcus equiABSTRACT
O objetivo deste trabalho foi avaliar a eficácia do florfenicol na dose usualmente empregada em equinos de 22 mg/kg pelas vias intravenosa, intramuscular e oral para o tratamento de adenite equina por Streptococcus equi. subsp. equi, usando a modelagem farmacocinética/farmacodinâmica (PK/PD Pharmacokinetic/Pharmacodynamic) e a simulação de Monte Carlo. Foi realizada uma simulação de Monte Carlo a partir dos parâmetros PK, logo depois, efetuou-se a modelagem PK/PD para determinar as taxas de eficácia do antimicrobiano para o tratamento dessa infecção bacteriana, de acordo com o valor da concentração inibitória mínima (CIM), em um intervalo de CIM de 0,125 4 µg/mL. Pela via intravenosa, a probabilidade de erradicação bacteriana foi de 100% para CIM até 0,5 µg/mL e efeito bacteriostático com probabilidades de 99% e 80% para CIMs de 2 e 4 µg/mL, respectivamente. Já pelas vias intramuscular e oral a probabilidade de se atingir o índice de erradicação bacteriológica foi de 100% para CIM de até 0,5 µg/mL, contudo, atinge valores de 80% e 81%, respectivamente, para CIM de 1 µg/mL considerando o efeito bactericida (p<0,01). Portanto, através desse estudo é evidenciado a eficácia do florfenicol até a CIM de 0,5 µg/mL para as três vias de administração citadas, entretanto, para CIMs superiores a esse valor, é imprescindível o ajuste da dose farmacológica, evitando falhas na terapêutica e possível resistência microbiana.
The objective of this study was to evaluate the efficacy of florfenicol at the dose usually used in horses of 22 mg/kg by intravenous, intramuscular and oral routes for the treatment of equine adenitis caused by Streptococcus equi. subsp. equi, using Pharmacokinetic/Pharmacodynamic (PK/PD) modeling and Monte Carlo simulation. A Monte Carlo simulation was performed from the PK parameters, then PK/PD modeling was performed to determine the antimicrobial efficacy rates for the treatment of this bacterial infection, according to the minimum inhibitory concentration (MIC) value, in a MIC range of 0.125 - 4 µg/mL. Intravenously, the probability of bacterial eradication was 100% for MICs up to 0.5 µg/mL, and the bacteriostatic effect was 99% and 80% for MICs of 2 and 4 µg/mL, respectively. However, for the intramuscular and oral routes, the probability of reaching the bacteriologic eradication index was 100% for MICs of up to 0.5 µg/mL, however, it reaches values of 80% and 81%, respectively, for MICs of 1 µg/mL considering the bactericidal effect (p<0.01). Therefore, through this study the efficacy of florfenicol is evidenced up to the MIC of 0.5 µg/mL for the three routes of administration cited, however, for MICs higher than this value, it is essential to adjust the pharmacological dose, avoiding failures in therapy and possible microbial resistance.
Subject(s)
Animals , Horse Diseases/therapy , Lymphadenitis/veterinary , Anti-Bacterial Agents/therapeutic use , Pharmacokinetics , Monte Carlo MethodABSTRACT
Caseous lymphadenitis (CLA) is an infectious chronic disease responsible for economic losses in sheep and goat breeding worldwide. CLA has no effective treatment, evidencing the vaccination schedule as the best control strategy. Although some commercial vaccines have been available, none of them provides total protection, which is sometimes insufficient and does not reach the same efficiency when compared in sheep and goats. They also have questionable safety levels and side effects. In light of this, several experimental vaccines are in development in order to improve safety, reproducibility, and protective immune response against the etiologic agent of CLA, Corynebacterium pseudotuberculosis. In this review, we discussed aspects as antigen, adjuvant, routes of administration, protection level, and animal models used in CLA vaccine development, as well the challenges and future perspectives. KEY POINTS: Caseous lymphadenitis (CLA) does not have an appropriate commercial vaccine. Different experimental vaccines are in development aiming to protect against Corynebacterium pseudotuberculosis. An ideal vaccine for CLA is necessary for the disease control.